secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001140361-23-039308
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q2 revenue $4.7M (+20% YoY); net loss $7.3M; guides Q3 growth 15-25%
-----------------------------------------------------------------------------

- Q2 revenue $4.7M (+20% YoY) within 15-25% guidance; H1 revenue $8.5M (+19%).
- Gross margin improved to 74% from 72%; operating income $0.9M with $1.25M one-time expense reversal.
- Net loss $7.3M vs net income $1.6M in Q2 2022 due to non-cash derivative liability losses.
- Q3 2023 revenue growth guidance 15-25% YoY; inventory constraints expected to ease in Q4.
- Recent: CEO Morgan Frank (May), President Andrew Walko (July), $3M asset-backed notes issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123039308/0001140361-23-039308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036123039308/brhc20057422_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-039308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer